Division of Rheumatology Archives
Study identifies potential new approach for treating lupus
Jan. 13, 2023—A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.
Vanderbilt mourns loss of former Rheumatology director Thomas
Nov. 21, 2022—James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.
VUMC to test whether Alzheimer’s drug can ease lupus symptoms
Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.
Rheumatoid arthritis and heart disease: a common path
Aug. 25, 2022—An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.
VUMC lauded for scleroderma treatment, research
Aug. 4, 2022—Vanderbilt University Medical Center was recently listed as a Designated Scleroderma Research and Treatment Center by the National Scleroderma Foundation.
Study shows genotype leads to discontinued, decreased medication
Jun. 29, 2022— by Jill Clendening Patients whose race is recorded as Black in their electronic health record (EHR) are more likely to have azathioprine, an immunosuppressant medication, discontinued or its dose reduced because their laboratory results show a low white blood cell count. This lab finding was not a factor of race, but instead was linked...
Rheumatoid arthritis: special deliveries
Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
Chung receives early investigator award from ASCPT
Sep. 16, 2021—Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
New Clinician Spotlight: Jason Springer
Apr. 20, 2021—Jason Springer, MD, MS, has joined Vanderbilt University Medical Center as associate professor of Medicine in the Division of Rheumatology and Immunology in the Department of Medicine. Springer is co-director of the Vanderbilt Vasculitis Center, where he will oversee vasculitis clinical trials.
Microbial RNA and rheumatoid arthritis
Jan. 11, 2021—Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases.
Vanderbilt University Medical Center to break ground on Hendersonville multi-specialty clinic
Feb. 14, 2020—Vanderbilt University Medical Center will soon break ground on a new 31,000-square-foot facility that will offer adult outpatient specialty care, along with limited pediatric specialty care and imaging services to the citizens of Sumner and surrounding counties.
Rheumatology’s Fuchs remembered for dedication to medicine, family
Oct. 30, 2019—Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.
